Johnson & Johnson is using the new technology to screen the 'potential universe' for promising chemical compounds or biologics, CIO Jim Swanson says

]]>https://postcall.pub/topic/178b72ee-5fac-46f4-8dae-ed31355b60b5/j-j-sees-ai-halving-the-time-to-generate-drug-development-leadsRSS for NodeFri, 01 May 2026 11:53:12 GMTTue, 28 Apr 2026 04:16:40 GMT60